A smiling man with glasses, a beard, wearing a suit and checkered shirt, standing against a gray background.

Michael Marchant

Director, Patents

London Croydon

In the biological and chemical fields, Michael Marchant’s expertise comes in all sizes. He works on nucleic acid sequencing and profiling technologies, often at the interface of biotechnology and machine learning, as well as in the fields of immunology and antibodies. He has a wealth of experience in small molecule pharmaceuticals and cellular technology, particularly stem cell biology and modified cellular mechanisms. His work also involves advising SMEs and large multinationals in the diagnostic and medical device fields.

Michael works closely with clients to advise on European and global filing strategies, understanding how local and foreign patent law can be navigated to get the best possible protection for his clients. He is regularly involved in contentious work, including due diligence advice and infringement and validity opinions, and he is considered a specialist in EPO opposition and appeal proceedings, regularly opposing competitors’ patents and defending clients’ own IP with an impressive track record of success.

Michael also regularly provides opinions on registered and unregistered design infringement and validity, as well as being heavily involved in registered design filings. He is a member of Murgitroyd’s design group.

Michael read Natural Sciences at the University of Cambridge, where he specialised in plant sciences (including plant pathology and plant genetics). He joined Murgitroyd in 2008 to head the London Office patent group, having spent almost six years at a leading London firm of patent attorneys.

Michael is based in our London Croydon office.
 

The logo of the Financial Times features the bold initials "FT" in black on a beige background, with "Financial Times" written below in dark blue.

Sector expertise

  • Diagnostic technology
  • Medical Technologies
  • Microbiology
  • Biotechnology
  • Molecular biology
  • Cellular technology
  • Stem cell biology
  • Immunology
  • Plant sciences
  • Plant pathology
  • Plant genetics
  • Small molecule pharmaceuticals
  • Orphan drugs
  • Opposition specialist

As you know, this is very commercially important to us, so this revocation is key to our business. Thank you so much for all of your hard work on this, and take a well-earned break after that gauntlet today!

Senior Patent Counsel, Biotechnology Company

Total revocation!!! I just wanted to drop a note to say congratulations and thank you! That hearing today was certainly long and detailed, and you did great through all the twists and turns.

Senior Patent Counsel, Biotechnology Company

You’ve done an absolutely fantastic job of effectively and efficiently managing our patent portfolio. I’m thankful we will get to continue working with you on our EP cases.

Senior Patent Counsel, Global Diagnostics Company

We work with a lot of foreign counsel from around the world, and Murgitroyd is the company we enjoy working with the most.

US Agent

Key contributor to our Life Sciences & Healthcare Team awarded Gold by the Financial Times

Financial Times European Leading Patent Law Firms, combined Pharmaceuticals, Biotechnology, Food & Healthcare awards - 2019, 2020, 2022, 2023 & 2024

Oh my gosh, I want to go do cartwheels!! Though I think I would probably injure myself. I will stick to the celebratory champagne instead! Such great news, thanks for all your advice and help in getting our evidence in order. Miracles can happen.

Partner, Specialising in Life Sciences and Biotechnology, US Law Firm

Mike, Fabien, thanks for handling the twists and turns of the hearing so well. Thank you for your input at an important moment. I really appreciate it and the outcome is very good for our company.

Senior Patent Counsel, Pioneering diagnostics Company

I’ll keep recommending you internally for these Strawman cases. We’ve had some good results together over the years.

UK IP Firm

Great job at the oral hearing and with all of the preparations that went into this. This is a great outcome!

US based biotechnology Company

Insights

All insights
The logo of the Financial Times features the bold initials "FT" in black on a beige background, with "Financial Times" written below in dark blue.
"IP STARS logo featuring bold dark blue text with a star in the letter 'A,' and yellow 'from Managing IP' text below, on a white background."
The logo of "The Legal 500" featuring the publication name in stylized text with a black and dark gray color scheme.
The SIAAM 300 logo features three red horizontal lines next to bold black and red text, with a minimalist design highlighting the brand name.
IAm 300 Global Leaders 2025 logo with black and red text and design elements on a gray background.
The SIAM 1000 logo features bold black and red text with three curved red lines on the left, creating a modern, dynamic design.
WTR 1000 logo with blue and black text and beige horizontal lines on a transparent background.
Logo featuring the words "LEXULOGY" and "INDEX" with a design of six dark circles arranged in two columns on the left side.
A round badge with a white interior and gold border, featuring a gold eagle emblem, Chinese characters on a red ribbon, and the text "2024" at the bottom.
The Déla Marken logo features three black stars with shooting lines inside a red circle and the words "DÉCIDEURS MAGAZINE" in bold black and red text below.
Logo for WIPR 2024 featuring the word "Diversity" and the phrase "Influential Woman in IP" on a teal background.
LBG logo featuring a purple circle with white text, alongside "Legal Benchmarking" and "Social Impact Awards 2024" in black and orange text.
A colorful icon with six petal-like shapes in blue, purple, green, and orange surrounding a central circle, with "IP INCLUSIVE" text and a tagline about diversity and inclusion.
A logo with interconnected circles forming a stylized design, accompanied by the text "ADAPT.legal" beneath it.
European Patent Pipeline Program (EPPP) logo with bold pink and dark blue text on a gray background.
Logo for the Legal Sustainability Alliance featuring the acronym "LSA" with leaf and wave designs, and text indicating membership for 2024.
A badge with a blue background, white text reads "Cyber Essentials Certified" with a green checkmark and a stylized checkmark graphic.
Cyber Essentials Plus logo with a blue and green checkmark next to the text on a dark background.
A stylized swoosh design in blue, green, and yellow colors with the text "bvea" and the tagline "invested in a better future" beneath it.
Green globe with swirling lines next to the text "United Kingdom Best Managed Companies" in black.